Multimodal brain imaging reveals structural differences in Alzheimer ’ s disease polygenic risk carriers : A study in healthy young adultsImaging Alzheimer ’ s disease polygenic risk

Cite this article as: Sonya F. Foley, Katherine E. Tansey, Xavier Caseras, Thomas Lancaster, Tobias Bracht, Greg Parker, Jeremy Hall, Julie Williams and David Linden, Multimodal brain imaging reveals structural differences in Alzheimer’s disease polygenic risk carriers: A study in healthy young adultsImaging Alzheimer’s disease polygenic risk, Biological Psychiatry, http://dx.doi.org/10.1016/j.biopsych.2016.02.033

[1]  I. Deary,et al.  Age-Dependent Pleiotropy Between General Cognitive Function and Major Psychiatric Disorders , 2016, Biological Psychiatry.

[2]  M. Gill,et al.  Common polygenic variation enhances risk prediction for Alzheimer's disease. , 2015, Brain : a journal of neurology.

[3]  H. Stefánsson,et al.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease , 2015, Circulation.

[4]  M. Weiner,et al.  Brain atrophy rates in first degree relatives at risk for Alzheimer's , 2014, NeuroImage: Clinical.

[5]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[6]  M. Fornage,et al.  ASSOCIATION OF ALZHEIMER DISEASE GWAS LOCI WITH MRI-MARKERS OF BRAIN AGING , 2014, Alzheimer's & Dementia.

[7]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[8]  Shaun M. Purcell,et al.  Statistical power and significance testing in large-scale genetic studies , 2014, Nature Reviews Genetics.

[9]  Olivier Colliot,et al.  Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. , 2014, Biochemical pharmacology.

[10]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[11]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[12]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[13]  Kate E. Macdonald,et al.  The Value of Hippocampal and Temporal Horn Volumes and Rates of Change in Predicting Future Conversion to AD , 2013, Alzheimer disease and associated disorders.

[14]  F. Dudbridge.  Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.

[15]  Alan C. Evans,et al.  Structural networks in Alzheimer's disease , 2013, European Neuropsychopharmacology.

[16]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[17]  J. Aggleton,et al.  Distinct subdivisions of the cingulum bundle revealed by diffusion MRI fibre tracking: Implications for neuropsychological investigations , 2013, Neuropsychologia.

[18]  Arthur W Toga,et al.  Recent Advances in Imaging Alzheimer's Disease 2 3 , 2022 .

[19]  Eric M Reiman,et al.  Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study , 2012, The Lancet Neurology.

[20]  R. Buckner,et al.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. , 2012, Cerebral cortex.

[21]  S. Lawrie,et al.  The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI , 2012, Translational Psychiatry.

[22]  D. Rujescu,et al.  APOE-ε4 genotype affects brain function without apparent micro- and macrostructural changes in young adults: A multimodal fMRI, DTI and VBM study , 2012, Alzheimer's & Dementia.

[23]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[24]  Derek K. Jones,et al.  How and how not to correct for CSF-contamination in diffusion MRI , 2012, NeuroImage.

[25]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[26]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[27]  Nick C Fox,et al.  Acceleration of cortical thinning in familial Alzheimer's disease , 2011, Neurobiology of Aging.

[28]  Derek K. Jones,et al.  Frontotemporal Connections in Episodic Memory and Aging: A Diffusion MRI Tractography Study , 2011, The Journal of Neuroscience.

[29]  Klaus P. Ebmeier,et al.  The APOE ɛ4 allele modulates brain white matter integrity in healthy adults , 2011, Molecular Psychiatry.

[30]  N. Jahanshad,et al.  Common Alzheimer's Disease Risk Variant Within the CLU Gene Affects White Matter Microstructure in Young Adults , 2011, The Journal of Neuroscience.

[31]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[32]  Stephen M. Smith,et al.  DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease , 2011, NeuroImage.

[33]  Paul M. Thompson,et al.  Neuroimaging Measures as Endophenotypes in Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[34]  H. Braak,et al.  The pathological process underlying Alzheimer’s disease in individuals under thirty , 2011, Acta Neuropathologica.

[35]  C. Duyckaerts.  Tau pathology in children and young adults: can you still be unconditionally baptist? , 2011, Acta Neuropathologica.

[36]  Anderson M. Winkler,et al.  Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies , 2010, NeuroImage.

[37]  Lesley Jones,et al.  Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. , 2010, Biochimica et biophysica acta.

[38]  Seth Love,et al.  Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.

[39]  Mert Sabuncu,et al.  Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.

[40]  In Chan Song,et al.  Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease , 2010, Neurobiology of Aging.

[41]  Giuseppe Scotti,et al.  A modified damped Richardson–Lucy algorithm to reduce isotropic background effects in spherical deconvolution , 2010, NeuroImage.

[42]  L H Kuller,et al.  Age, Alzheimer disease, and brain structure , 2009, Neurology.

[43]  Chunshui Yu,et al.  Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta‐analyses of MRI studies , 2009, Hippocampus.

[44]  N. Intrator,et al.  Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.

[45]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[46]  P. Kochunov,et al.  Heritability of Volume, Surface Area and Thickness for Anatomically Defined Cortical Brain Regions Estimated in a Large Extended Pedigree , 2009, NeuroImage.

[47]  Alexander Leemans,et al.  The B‐matrix must be rotated when correcting for subject motion in DTI data , 2009, Magnetic resonance in medicine.

[48]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[49]  P. Sachdev,et al.  In Vivo Hippocampal Measurement and Memory: A Comparison of Manual Tracing and Automated Segmentation in a Large Community-Based Sample , 2009, PloS one.

[50]  Stefan J. Teipel,et al.  Novel MRI techniques in the assessment of dementia , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[52]  George Bartzokis,et al.  Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.

[53]  Nick C Fox,et al.  Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.

[54]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[55]  Y. Zang,et al.  Voxel-based detection of white matter abnormalities in mild Alzheimer disease , 2006, Neurology.

[56]  G. Zubicaray,et al.  Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.

[58]  Jonas Persson,et al.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory , 2006, Neuroscience Letters.

[59]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[60]  Derek K Jones,et al.  Applications of diffusion‐weighted and diffusion tensor MRI to white matter diseases – a review , 2002, NMR in biomedicine.

[61]  M. Albert,et al.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.

[62]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[63]  S. Black,et al.  Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s disease , 1998, Neuropsychologia.

[64]  A. Convit,et al.  Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.

[65]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[66]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[67]  C. Jack,et al.  Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. , 1989, Radiology.

[68]  Cedric E. Ginestet,et al.  No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents. , 2014, Journal of Alzheimer's disease : JAD.

[69]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[70]  P. Sachdev,et al.  APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age. , 2012, Journal of Alzheimer's disease : JAD.

[71]  P. Lewczuk,et al.  Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers. , 2011, Journal of Alzheimer's disease : JAD.

[72]  Emiliano Macaluso,et al.  Grey and white matter changes at different stages of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[73]  Nick C Fox,et al.  Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[74]  R. Honea,et al.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. , 2009, Journal of Alzheimer's disease : JAD.

[75]  Jan Sijbers,et al.  ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data , 2009 .

[76]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[77]  J. Brandt.  The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. , 1991 .